Abstract
Saeideh Tavajoh, Bianca E Suur, Madison Clark, Adriana Araceli Becerril-Campos, Elia Velasco, Brigita Medelytė, Line Boel Nørregaard, Stine Julie Tingskov, Amanda Bæk, Lykke Skaarup, Erik Schröder, Maryam Dost, Sigrid Bjerge Gribsholt, Jens Meldgaard Bruun, Marianne Quiding Järbrink, Sofia N. Nyström, Ida Bergström, Catherine Åhlund, Jane Palsgaard Pedersen, Niels Jessen, András Harazin, Henrik Holm Thomsen, Per‐Anders Jansson, Robert Blomgran, Stephan C. Lange, Matúš Soták, Emma Börgeson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1136/bmjdrc-2025-005118
10.1136/bmjdrc-2025-005118
TREM1 signaling amplifies neutrophil-mediated inflammation in inflammatory bowel disease
10.1038/s41467-026-75319-8 · 2026
State of Cutaneous Microcirculation in Patients with Obesity
10.36740/wlek202109103 · 2021
10.1038/ijo.2009.199
10.1038/ijo.2009.199
10.1111/joim.12384
10.1111/joim.12384
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes
10.1016/j.molmet.2015.04.002 · 2015
10.3389/fimmu.2017.00254
10.3389/fimmu.2017.00254
10.1210/endrev/bnaa004
10.1210/endrev/bnaa004
An overview of obesity-related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes. Diabetes
10.1111/dom.16263 · 2025
10.1146/annurev-nutr-071816-064800
10.1146/annurev-nutr-071816-064800
Metalloproteinases and Wound Healing
10.1089/wound.2014.0581 · 2015
10.1038/nrm1619
10.1038/nrm1619
Insights on the role of the chemokine CCL8 in pathology
10.1016/j.cellsig.2025.111951 · 2025
Joint effect of BMI and metabolic status on mortality among adults: a population-based longitudinal study in United States
10.1038/s41598-024-53229-3 · 2024
10.1042/ebc20200018
10.1042/ebc20200018
10.1038/s41590-020-0646-0
10.1038/s41590-020-0646-0
10.1159/000088261
10.1159/000088261
10.1016/j.ajpath.2015.01.020
10.1016/j.ajpath.2015.01.020
Different associations of adipokines in lean and healthy adults
2014
Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
10.1038/s41598-021-87207-w · 2021
10.1111/iwj.70035
10.1111/iwj.70035
10.1155/2012/476380
10.1155/2012/476380
10.1016/j.diabres.2014.04.006
10.1016/j.diabres.2014.04.006
Serum Tumor Necrosis Factor Alpha (TNF-alpha) Levels in Obese and Overweight Adults: Correlations With Metabolic Syndrome and Inflammatory Markers
2024
High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome
10.1007/s40618-023-02050-2 · 2023
Mechanisms Involved in Childhood Obesity-Related Bone Fragility
10.3389/fendo.2019.00269 · 2019
10.1002/jcp.22385
10.1002/jcp.22385
10.1016/j.pharmthera.2020.107670
10.1016/j.pharmthera.2020.107670
10.3109/03008207.2013.822865
10.3109/03008207.2013.822865
10.1016/j.mvr.2011.01.002
10.1016/j.mvr.2011.01.002
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
2021
10.1038/s41591-019-0675-0
10.1038/s41591-019-0675-0
10.1016/j.biocel.2007.10.024
10.1016/j.biocel.2007.10.024
10.3389/fimmu.2022.861931
10.3389/fimmu.2022.861931
10.1093/bioinformatics/btw313
10.1093/bioinformatics/btw313
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
10.1038/s41392-025-02124-y · 2025
Tumor Necrosis Factor: A Master Regulator in Inflammation and Disease-Pathways, Implications, and Breakthrough Therapies
10.1177/10799907261418982 · 2026
10.1007/s00125-016-4036-y
10.1007/s00125-016-4036-y
10.3389/fimmu.2022.876515
10.3389/fimmu.2022.876515
Update on the epidermal differentiation complex
10.2741/4001 · 2012
ST2L promotes VEGFA-mediated angiogenesis in gastric cancer by activating TRAF6/PI3K/Akt/NF-kappaB pathway via IL-33
10.1038/s41598-024-76763-6 · doi-reference
High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8(+) T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients
10.1177/03946320251346823 · doi-reference
CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
10.1038/ncomms11674 · doi-reference
An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality
10.1001/jamanetworkopen.2021.8505 · doi-reference
10.1089/omi.2011.0118
10.1089/omi.2011.0118 · doi-reference
10.3389/fimmu.2012.00368
10.3389/fimmu.2012.00368 · doi-reference
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesis
10.1016/j.jaci.2025.08.033 · doi-reference
Skin wound closure delay in metabolic syndrome correlates with SCF deficiency in keratinocytes
10.1038/s41598-020-78244-y · doi-reference
Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas
10.1016/j.jinf.2023.03.020 · doi-reference
10.1073/pnas.2114739119
10.1073/pnas.2114739119 · doi-reference
10.1038/s41423-025-01380-w
10.1038/s41423-025-01380-w · doi-reference
10.1038/oby.2011.142
10.1038/oby.2011.142 · doi-reference
Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 - An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives
10.2147/jir.s374060 · doi-reference
Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis
10.1097/md.0000000000034797 · doi-reference
10.3389/fimmu.2021.648182
10.3389/fimmu.2021.648182 · doi-reference
10.1101/gad.267708.115
10.1101/gad.267708.115 · doi-reference
10.3389/fimmu.2016.00160
10.3389/fimmu.2016.00160 · doi-reference
Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: A systematic review and meta-analysis
10.1016/j.numecd.2023.09.002 · doi-reference
10.1016/j.cmet.2017.07.008
10.1016/j.cmet.2017.07.008 · doi-reference
Metabolic syndrome and inflammatory skin conditions
10.1097/mop.0000000000000790 · doi-reference
10.1210/jc.2010-1170
10.1210/jc.2010-1170 · doi-reference
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients
10.1016/j.numecd.2022.12.008 · doi-reference
10.1038/s41574-024-01047-y
10.1038/s41574-024-01047-y · doi-reference
10.3390/ijms20184658
10.3390/ijms20184658 · doi-reference
10.1242/jcs.02346
10.1242/jcs.02346 · doi-reference
10.1096/fj.06-7227rev
10.1096/fj.06-7227rev · doi-reference
10.1007/s11154-023-09796-3
10.1007/s11154-023-09796-3 · doi-reference
Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability
10.1111/j.1365-2125.2004.02344.x · doi-reference
10.1016/j.jaci.2020.03.041
10.1016/j.jaci.2020.03.041 · doi-reference
10.1136/bmjopen-2020-039996
10.1136/bmjopen-2020-039996 · doi-reference
10.1016/s0140-6736(17)32814-3
10.1016/s0140-6736(17)32814-3 · doi-reference
10.1161/circulationaha.112.122556
10.1161/circulationaha.112.122556 · doi-reference
10.1056/nejmoa1707914
10.1056/nejmoa1707914 · doi-reference
10.1016/s0140-6736(21)00520-1
10.1016/s0140-6736(21)00520-1 · doi-reference
10.1016/j.cellsig.2018.11.004
10.1016/j.cellsig.2018.11.004 · doi-reference
10.1111/bph.12713
10.1111/bph.12713 · doi-reference
Epithelial-derived cytokines in the pathogenesis of severe asthma
10.3389/falgy.2025.1681147 · doi-reference
Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity
10.1016/j.cmet.2024.03.002 · doi-reference
FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery
10.1016/j.ebiom.2024.105458 · doi-reference
10.1093/cei/uxac079
10.1093/cei/uxac079 · doi-reference